When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Gynecologic oncology - Wikipedia

   en.wikipedia.org/wiki/Gynecologic_oncology

   Gynecologic oncology is a specialized field of medicine that focuses on cancers of the female reproductive system, including ovarian cancer, uterine cancer, vaginal cancer, cervical cancer, and vulvar cancer. As specialists, they have extensive training in the diagnosis and treatment of cancers.

3. Ovarian cancer - Wikipedia

   en.wikipedia.org/wiki/Ovarian_cancer

   People having ovarian cancer surgery are typically hospitalized afterwards for 3–4 days and spend around a month recovering at home. [108] Surgery outcomes are best at hospitals that do a large number of ovarian cancer surgeries. [29] It is unclear if laparoscopy or laparotomy is better or worse for FIGO stage I ovarian cancer. [109]

4. Ovarian clear-cell carcinoma - Wikipedia

   en.wikipedia.org/wiki/Ovarian_clear-cell_carcinoma

   According to research, most ovarian cancers start at the epithelial layer which is the lining of the ovary. Within this epithelial group ovarian clear-cell carcinoma makes up 5–10%. It was recognized as a separate category of ovarian cancer by the World Health Organization in 1973. Its incidence rate differs across various ethnic groups.

5. Ovarian remnant syndrome - Wikipedia

   en.wikipedia.org/wiki/Ovarian_remnant_syndrome

   The mainstay of treatment is surgery to remove the residual ovarian tissue. Women with ORS with a pelvic mass should have appropriate evaluation for malignancy ( cancer ). Hormonal therapy to suppress ovarian function is an alternative treatment for those who refuse surgery, or those who are not candidates for surgery. [ 3 ]

6. US FDA grants full approval to AbbVie's ovarian cancer therapy

   www.aol.com/news/us-fda-grants-full-approval...

   (Reuters) -The U.S. Food and Drug Administration said on Friday it had granted traditional approval for AbbVie's "guided missile" cancer therapy, Elahere, for patients with a type of ovarian cancer.

7. Mirvetuximab soravtansine - Wikipedia

   en.wikipedia.org/wiki/Mirvetuximab_soravtansine

   Mirvetuximab soravtansine, sold under the brand name Elahere, is a medication used as a treatment for epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. [ 2 ] [ 5 ] Mirvetuximab soravtansine is a folate receptor alpha directed antibody and microtubule inhibitor conjugate.